跳至主要内容
临床试验/EUCTR2008-006238-87-GB
EUCTR2008-006238-87-GB进行中(未招募)1 期

Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K - Improving stability of anticoagulation through vitamin K

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 180 人开始时间: 2009年10月14日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult patients with indications for at least 6 months anticoagulation therapy with warfarin with target INR 2-3 attending the Newcastle upon Tyne Anticoagulant Monitoring Service.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Abnormal biochemical tests of hepatic or renal function, cognitive impairment.

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验

Improving the safety and efficacy of anticoagulation... | 临床试验